High materiality7/10
MapLight Therapeutics (MPLT) PT Lowered to $43 at Needham
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Needham lowers MPLT price target to $43; current price $12.60.
- MPLT: Target $43; price $12.60; Needham.
Key facts
- 01
Target: $43
- 02
Posted price: $12.6
- 03
Analyst firm: Needham
- 04
Analyst: Ami Fadia
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.